92 related articles for article (PubMed ID: 8820951)
1. P-glycoprotein, multidrug resistance and protein kinase C.
Fine RL; Chambers TC; Sachs CW
Stem Cells; 1996 Jan; 14(1):47-55. PubMed ID: 8820951
[TBL] [Abstract][Full Text] [Related]
2. P-Glycoprotein, Multidrug Resistance and Protein Kinase C.
Fine RL; Chambers TC; Sachs CW
Oncologist; 1996; 1(4):261-268. PubMed ID: 10388000
[TBL] [Abstract][Full Text] [Related]
3. Role of protein kinase C in the modulation of multidrug resistance: expression of the atypical gamma isoform of protein kinase C does not confer increased resistance to doxorubicin.
Ahmad S; Trepel JB; Ohno S; Suzuki K; Tsuruo T; Glazer RI
Mol Pharmacol; 1992 Dec; 42(6):1004-9. PubMed ID: 1362242
[TBL] [Abstract][Full Text] [Related]
4. Reduced daunomycin accumulation in drug-sensitive and multidrug-resistant human carcinoma KB cells following phorbol ester treatment: a potential role for protein kinase C in reducing drug influx.
Drew L; Groome N; Warr JR; Rumsby MG
Oncol Res; 1996; 8(6):249-57. PubMed ID: 8895200
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?
Ratnasinghe D; Daschner PJ; Anver MR; Kasprzak BH; Taylor PR; Yeh GC; Tangrea JA
Anticancer Res; 2001; 21(3C):2141-7. PubMed ID: 11501838
[TBL] [Abstract][Full Text] [Related]
6. Interaction of P-glycoprotein with protein kinase C in human multidrug resistant carcinoma cells.
Yang JM; Chin KV; Hait WN
Cancer Res; 1996 Aug; 56(15):3490-4. PubMed ID: 8758935
[TBL] [Abstract][Full Text] [Related]
7. Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells.
Scala S; Dickstein B; Regis J; Szallasi Z; Blumberg PM; Bates SE
Clin Cancer Res; 1995 Dec; 1(12):1581-7. PubMed ID: 9815959
[TBL] [Abstract][Full Text] [Related]
8. Functional role of phosphorylation of the multidrug transporter (P-glycoprotein) by protein kinase C in multidrug-resistant MCF-7 cells.
Aftab DT; Yang JM; Hait WN
Oncol Res; 1994; 6(2):59-70. PubMed ID: 7949466
[TBL] [Abstract][Full Text] [Related]
9. Changes in protein kinase C subspecies protein expression and activity in a series of multidrug-resistant human KB carcinoma cell lines.
Drew L; Groome N; Hallam TJ; Warr JR; Rumsby MG
Oncol Res; 1994; 6(9):429-38. PubMed ID: 7703529
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential.
Alemán C; Annereau JP; Liang XJ; Cardarelli CO; Taylor B; Yin JJ; Aszalos A; Gottesman MM
Cancer Res; 2003 Jun; 63(12):3084-91. PubMed ID: 12810633
[TBL] [Abstract][Full Text] [Related]
11. Increase of nuclear phosphatidylinositol 4,5-bisphosphate and phospholipase C beta 1 is not associated to variations of protein kinase C in multidrug-resistant Saos-2 cells.
Zini N; Neri LM; Ognibene A; Scotlandi K; Baldini N; Maraldi NM
Microsc Res Tech; 1997 Feb; 36(3):172-8. PubMed ID: 9080407
[TBL] [Abstract][Full Text] [Related]
12. (+/-)-3'-O, 4'-O-dicynnamoyl-cis-khellactone, a derivative of (+/-)-praeruptorin A, reverses P-glycoprotein mediated multidrug resistance in cancer cells.
Shen X; Chen G; Zhu G; Fong WF
Bioorg Med Chem; 2006 Nov; 14(21):7138-45. PubMed ID: 16875827
[TBL] [Abstract][Full Text] [Related]
13. Correlation of multidrug resistance with up-regulation of protein kinase C expression in KBV200 cells.
Yuan YW; Sun AM; Li CG
Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1341-3, 1356. PubMed ID: 16305951
[TBL] [Abstract][Full Text] [Related]
14. Stable expression of a cDNA encoding rat brain protein kinase C-beta I confers a multidrug-resistant phenotype on rat fibroblasts.
Fan D; Fidler IJ; Ward NE; Seid C; Earnest LE; Housey GM; O'Brian CA
Anticancer Res; 1992; 12(3):661-7. PubMed ID: 1622123
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in P-glycoprotein-mediated multidrug resistance reversal mechanisms.
Li X; Li JP; Yuan HY; Gao X; Qu XJ; Xu WF; Tang W
Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):607-17. PubMed ID: 18193112
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural features and P-glycoprotein immunolocalization in Saos-2/DX580 multidrug-resistant human osteosarcoma cells.
Maraldi NM; Zini N; Sabatelli P; Valmori A; Scotlandi K; Serra M; Baldini N
J Submicrosc Cytol Pathol; 1996 Jan; 28(1):93-100. PubMed ID: 8929631
[TBL] [Abstract][Full Text] [Related]
17. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.
Newman MJ; Rodarte JC; Benbatoul KD; Romano SJ; Zhang C; Krane S; Moran EJ; Uyeda RT; Dixon R; Guns ES; Mayer LD
Cancer Res; 2000 Jun; 60(11):2964-72. PubMed ID: 10850444
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines.
Fantappiè O; Solazzo M; Lasagna N; Platini F; Tessitore L; Mazzanti R
Cancer Res; 2007 May; 67(10):4915-23. PubMed ID: 17510421
[TBL] [Abstract][Full Text] [Related]
19. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
20. Establishment of doxorubicin-resistant human bladder cancer cell line (BUI-87/ADMR) and its mechanism of multidrug resistance.
Guo H; Lu G; Xiong X; Dong J; Liu S
Chin Med J (Engl); 1997 Mar; 110(3):167-72. PubMed ID: 9594332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
